Docetaxel in Non-Small Cell Lung Cancer: Impact on Quality of Life and Pharmacoeconomics

Author： Horn Leora Visbal Antonio Leighl Natasha B.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.5, 2007-01, pp. : 411-428

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel in non-small cell lung cancer: a review

By Davies Angela M Lara Jr Primo N Mack Philip C Gandara David R

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 553-565

Informa Healthcare

Access to resources Recommend Favorite

Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

By Trippoli S. Vaiani M. Lucioni C. Messori A.

PharmacoEconomics, Vol. 19, Iss. 8, 2001-01 ,pp. : 855-863

Adis International

Access to resources Recommend Favorite

Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer

By Schuette W.

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 161-168

Adis International

Access to resources Recommend Favorite

Docetaxel: A Review of its Use in Non-Small Cell Lung Cancer

By Comer A.M. Goa K.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 53-80

Adis International

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite